BBH
VanEck Biotech ETF
1W: +0.7%
1M: -6.0%
3M: -3.7%
YTD: -2.5%
1Y: +13.8%
3Y: +19.3%
5Y: +7.2%
$184.90
-1.41 (-0.76%)
After Hours: $191.00 (+6.10, +3.30%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$398M
Holdings25
Top 10 Wt72.4%
Beta0.79
% Profitable63%
Coverage100%
Portfolio Valuation
P/E24.0
P/B7.3
P/S5.7
EV/EBITDA15.0
P/FCF22.8
PEG2.17
Profitability & Returns
Gross Margin80.3%
Net Margin22.9%
ROE31.5%
ROA10.2%
ROIC18.1%
Div Yield0.97%
Leverage & Liquidity
Debt/Equity1.23
Debt/Assets0.42
Net Debt/EBITDA1.4x
Interest Cov7.4x
Current Ratio1.65
Quick Ratio1.35
Growth (YoY)
Revenue+20.5%
Net Income+97.8%
EPS+99.8%
FCF+47.9%
EBITDA+88.8%
Rev CAGR 3Y+20.7%
Quality Scores
Piotroski F6.6
Altman Z7.44
IS Quality72.0
IS Overall64.5
IS Value46.6
Median P/E20.2
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 25 | 99.8% | 19.4 |
| Other | 2 | 0.2% | — |
Smart Money Overlap
3 holdings with signals
Showing 27 of 27 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 17.04% | $66.4M | 469,824 | 20.0 | $171.6B | Healthcare |
| 2 | Amgen Inc | AMGN | 16.68% | $65.0M | 184,885 | 24.7 | $190.8B | Healthcare |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 9.35% | $36.4M | 80,708 | 29.2 | $115.6B | Healthcare |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 7.67% | $29.9M | 40,154 | 17.3 | $77.9B | Healthcare |
| 5 | Argenx Se | ARGX | 3.96% | $15.4M | 22,521 | 37.7 | $43.1B | Healthcare |
| 6 | Natera Inc | NTRA | 3.80% | $14.8M | 74,920 | -129.0 | $28.0B | Healthcare |
| 7 | Alnylam Pharmaceuticals Inc | ALNY | 3.60% | $14.0M | 44,593 | 139.8 | $43.6B | Healthcare |
| 8 | Insmed Inc | INSM | 3.48% | $13.6M | 95,009 | -24.8 | $32.0B | Healthcare |
| 9 | Iqvia Holdings Inc | IQV | 3.47% | $13.5M | 80,911 | 21.1 | $28.1B | Healthcare |
| 10 | Biogen Inc | BIIB | 3.37% | $13.1M | 71,963 | 21.7 | $27.8B | Healthcare |
| 11 | United Therapeutics Corp | UTHR | 3.33% | $13.0M | 24,474 | 17.8 | $23.7B | Healthcare |
| 12 | Beone Medicines Ltd | ONC | 3.03% | $11.8M | 41,836 | 156.7 | $30.3B | Healthcare |
| 13 | Moderna Inc | MRNA | 2.90% | $11.3M | 215,959 | -7.4 | $21.1B | Healthcare |
| 14 | Illumina Inc | ILMN | 2.51% | $9.8M | 79,703 | 22.6 | $19.3B | Healthcare |
| 15 | Exact Sciences Corp | EXAS | 2.32% | $9.0M | 87,035 | -95.7 | $20.0B | Healthcare |
| 16 | Incyte Corp | INCY | 1.88% | $7.3M | 79,479 | 14.2 | $18.4B | Healthcare |
| 17 | Neurocrine Biosciences Inc | NBIX | 1.85% | $7.2M | 55,117 | 27.6 | $13.2B | Healthcare |
| 18 | Biontech Se | BNTX | 1.77% | $6.9M | 76,752 | -16.3 | $22.3B | Healthcare |
| 19 | Icon Plc | ICLR | 1.35% | $5.3M | 54,100 | 13.2 | $7.6B | Healthcare |
| 20 | Bio-Techne Corp | TECH | 1.17% | $4.6M | 89,772 | 101.1 | $8.2B | Healthcare |
| 21 | Biomarin Pharmaceutical Inc | BMRN | 1.17% | $4.6M | 82,261 | 30.6 | $10.7B | Healthcare |
| 22 | Charles River Laboratories Internationa | CRL | 1.13% | $4.4M | 27,967 | -56.6 | $8.2B | Healthcare |
| 23 | Qiagen Nv | QIA.DE | 1.12% | $4.4M | 107,882 | 19.5 | $7.2B | Healthcare |
| 24 | Repligen Corp | RGEN | 0.97% | $3.8M | 31,987 | 132.0 | $6.4B | Healthcare |
| 25 | Tempus Ai Inc | TEM | 0.92% | $3.6M | 74,017 | -32.5 | $8.1B | Healthcare |
| 26 | -USD CASH- Cash | — | 0.10% | $408,542 | 408,542 | — | — | — |
| 27 | Other/Cash Cash | — | 0.06% | $224,342 | — | — | — | — |